Annual Shareholders Equity
$288.39 M
-$141.67 M-32.94%
December 31, 2023
Summary
- As of February 7, 2025, NAMS annual stockholders equity is $288.39 million, with the most recent change of -$141.67 million (-32.94%) on December 31, 2023.
- During the last 3 years, NAMS annual shareholders equity has risen by +$292.79 million (+6655.13%).
- NAMS annual shareholders equity is now -32.94% below its all-time high of $430.07 million, reached on December 31, 2022.
Performance
NAMS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$378.86 M
-$8.58 M-2.21%
September 30, 2024
Summary
- As of February 7, 2025, NAMS quarterly stockholders equity is $378.86 million, with the most recent change of -$8.58 million (-2.21%) on September 30, 2024.
- NAMS quarterly shareholders equity is now -17.44% below its all-time high of $458.89 million, reached on June 30, 2023.
Performance
NAMS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NAMS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.9% | - |
| 3 y3 years | +6655.1% | -11.9% |
| 5 y5 years | +6655.1% | -11.9% |
NAMS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | +411.6% | -17.4% | +572.0% |
| 5 y | 5-year | -32.9% | +6655.1% | -17.4% | +572.0% |
| alltime | all time | -32.9% | +6655.1% | -17.4% | +572.0% |
NewAmsterdam Pharma Company NV Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $378.86 M(-2.2%) |
| Jun 2024 | - | $387.44 M(-5.9%) |
| Mar 2024 | - | $411.80 M(+42.8%) |
| Dec 2023 | $288.39 M | $288.39 M(-37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $458.89 M(+6.7%) |
| Dec 2022 | $430.07 M(+662.9%) | $430.07 M(+123.2%) |
| Jun 2022 | - | $192.65 M(+241.7%) |
| Dec 2021 | $56.37 M(-1381.4%) | $56.37 M |
| Dec 2020 | -$4.40 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual stockholders equity?
- What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual stockholders equity?
The current annual shareholders equity of NAMS is $288.39 M
What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual stockholders equity is $430.07 M
What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
Over the past year, NAMS annual stockholders equity has changed by -$141.67 M (-32.94%)
What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
The current quarterly shareholders equity of NAMS is $378.86 M
What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly stockholders equity is $458.89 M